19
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T29908 |
Alprostadil ethyl ester
Prostaglandin E1 ethyl ester,PGE1 ethyl ester |
||
Alprostadil ethyl ester is a biochemical used in the treatment of scleroderma. | |||
T29907 |
Alprostadil sodium
PGE1 sodium salt,Prostaglandin E1 sodium |
||
Alprostadil sodium 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 | |||
T15757 |
Limaprost
17α,20-dimethyl-δ2-PGE1,利马前列素,OP1206,ONO1206 |
PGE Synthase | Immunology/Inflammation |
Limaprost (17α,20-dimethyl-δ2-PGE1) 是PGE1类似物,也是口服具有活性的血管舒张剂。它能够增加血流量以及减少血小板聚集。它具有抗心绞痛的功能,可用于疼痛的缓解,以及用于研究缺血性症状。 | |||
T36775 |
13,14-dihydro Prostaglandin E1
13,14-dihydro Prostaglandin E1 |
||
13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound. It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively. 13,14-dihydro PGE1 is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE1 which has an IC50 value of 40 nM. Also, 13,14-dihydro PGE1 was shown to activate adenylate cyclase in NCB-20 hyb... | |||
T34550 |
SC 31391
SC31391,SC-31391 |
||
SC 31391 is a PGE1 analog. | |||
T36726 |
6-keto Prostaglandin E1
6-keto Prostaglandin E1 |
||
6-keto Prostaglandin E1 是 PGE1 的生物活性衍生物,在抗血小板聚集和解聚作用方面发挥作用。 | |||
T36147 |
13,14-dihydro-15-keto Prostaglandin E1
13,14-dihydro-15-keto Prostaglandin E1 |
||
13,14-dihydro-15-keto Prostaglandin E1 可抑制 ADP 诱导的人离体富血小板血浆中的血小板聚集(IC50=14.8 μg/mL),也是 PGE1 代谢物。 | |||
T36214 |
16,16-dimethyl Prostaglandin E1
16,16-dimethyl Prostaglandin E1 |
||
16,16-dimethyl Prostaglandin E1 是 PGE1 (T1626) 类似物,可诱导支气管收缩和血管平滑肌收缩,并抑制吲哚美辛诱导的细胞伸长。 | |||
T36154 |
15(S)-15-methyl Prostaglandin E2
15(S)-15-methyl Prostaglandin E2 |
||
15(S)-15-methyl PGE2 is a potent, metabolically stable analog of PGE2. It is a potent gastric antisecretory and antiulcer compound. 15(S)-15-methyl PGE2 binds to human myometrium with twice the affinity of PGE2 and is ten times more potent than PGE1 in contracting uterine smooth muscle. | |||
T73346 |
SC 34301
Enisoprost |
||
SC 34301 (Enisoprost)为有效的口服活性PGE1类似物,显著降低细菌移位并提升烧伤小鼠存活率。 | |||
T37773 |
tetranor-PGEM
tetranor-Prostaglandin E Metabolite,tetranor-PGEM |
||
tetranor-PGEM is the major urinary metabolite of PGE1 and PGE2, and is used as a marker of PGE2 biosynthesis.[1],[2] About 15% of an infused dose of PGE2 appears as this metabolite in the urine of humans. Normal healthy males excrete 7-40 μg of tetranor-PGEM over a 24-hour period.[1] | |||
T36209 |
15-keto Prostaglandin A1
15-keto Prostaglandin A1 |
||
Prostaglandin A1 (PGA1) was first isolated as a dehydration product of the PGE1 compounds found in human semen. 15-keto PGA1 is a metabolite of PGA1, produced by 15-hydroxy PG dehydrogenase. It can be produced from PGA1 in pig lung, trachea, aorta, and pulmonary artery tissue preparations. 15-keto PGA1, given at a concentration of 6 μM, causes vasoconstriction of rabbit lung that is comparable to that induced by angiotensin II. | |||
T36157 |
8-iso Prostaglandin A1
8-iso Prostaglandin A1 |
||
8-iso Prostaglandin A1 (8-iso PGA1) is an isoprostane and a member in a large family of prostanoids of non-cyclooxygenase origin. It occurs as a common minor impurity in most commercial preparations of PGE1. The biological activity of 8-iso PGA1 has not been studied in depth or reported in the literature. | |||
T70865 |
BMY-42393
|
||
BMY-42393 is orally active and selective platelet aggregation inhibitor. BMY-42393 is also a prostacyclin partial agonist that inhibited ADP, collagen and thrombin-induced platelet aggregation (IC50 range 0.3 - 2.0 microM). BMY-42393 stimulated platelet adenylate cyclase activity (EC50 = 25 nM). Platelets treated with BMY 42393 showed an elevation of cAMP levels and activation of cAMP-dependent protein kinase. BMY 42393 also inhibited thrombin-induced elevation of intracellular free calcium. B... | |||
T37233 |
(±)14(15)-EpEDE
|
||
8,11,14-Eicosatrienoic acid, also known as dihomo-γ-linolenic acid , is a polyunsaturated fatty acid (PUFA) produced from γ-linolenic acid by the action of fatty acid elongases. It can be metabolized by the cyclooxygenase pathway to produce 1-series prostaglandins (PGs) (e.g., PGE1). (±)14(15)-EpEDE is an EpEDE acid formed from 8,11,14-eicosatrienoic acid. This monoepoxide can be generated from the PUFA, in vitro, by the action of a strong oxidizing agent. Alternatively, this compound may be pro... | |||
T36167 |
8-iso-15-keto Prostaglandin F2β
8-iso-15-keto Prostaglandin F2β |
||
8-iso Prostaglandin F2β (8-iso PGF2β) is an isomer of PGF2α of non-enzymatic origin. It is one of 64 possible isomers of PGF2α which can be produced by free radical peroxidation of arachidonic acid. 8-iso PGF2β exhibits very weak contraction of human umbilical vein artery and does not promote aggregation of human whole blood. However, 8-iso PGF2β moderately contracts both the canine and porcine pulmonary vein, although the effect is much weaker than that exhibited by other isoprostanes such as 8... | |||
T83807 |
Rp-Adenosine-5'-O-(1-thiotriphosphate) sodium
Rp-ATP-α-S |
||
Rp-Adenosine-5'-O-(1-thiotriphosphate)(Rp-ATP-α-S)是一种含硫核苷酸衍生物ATP-α-S的异构体,同时也是嘌呤P2Y1受体的激动剂。在表达人类P2Y1受体的HEK293细胞中,Rp-ATP-α-S能增加钙的动员(EC50 = 75 nM)。该化合物与洗涤的人类孤立血小板结合(Ki = 156 nM),抑制由ADP引发的人类富血小板血浆(PRP)的聚集(pA2 = 4.74),并且能够抑制前列腺素E1(PGE1)在人类孤立PRP中引发的cAMP产生(pA2 = 5.26)。同时,Rp-ATP-α-S还能引起用氨基甲酰胆碱预先缩紧的豚鼠结肠条带的松弛(EC50 = 56 nM)。此外,Rp-ATP-α-S已经被用于合成被细菌核糖开关识别的环状二核苷酸。 | |||
T62532 |
MRS2395
|
||
MRS2395 是一种二戊酰衍生物,是一种 P2Y12 受体的有效拮抗剂。MRS2395 抑制 ADP 诱导的血小板活化 (Ki: 3.6 μM)。MRS2395 在 PGE1 存在下,对大鼠血小板中 ADP 诱导的 cAMP 具有抑制作用 (IC50: 7 μM)。MRS2395 增强血小板致密颗粒释放以响应 TRAP-6。 | |||
T37441 |
KMN-80
|
||
The prostaglandin E receptor 4 (EP4) is one of four G protein-coupled receptors that mediate the actions of prostaglandin E2 . Binding of PGE2 to the EP4 receptor causes an increase in intracellular cyclic AMP, which plays important roles in bone formation and resorption, cancer, and atherosclerosis. KMN-80 is a substituted γ-lactam (pyrrolidinone) derivative of PGE1 that acts as a selective and potent agonist of EP4 with an IC50 value of 3 nM (IC50 = 1.4 μM for EP3 and > 10 μM for all other pro... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1626 |
Prostaglandin E1
前列地尔,PGE1,列腺素E1,Alprostadil |
Endogenous Metabolite; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism |
Prostaglandin E1 (Alprostadil) 是一种前列腺素受体配体,对小鼠 EP1、EP2、EP3、EP4和 IP 的 Ki 值分别为 36、10、1.1、2.1 和 33 nM。它诱导血管舒张并抑制血小板聚集,可作为血管扩张剂用于外周血管疾病的研究。 | |||
TQ0262 |
Dihomo-γ-linolenic acid
Diroleuton,顺式-8,11,14-二十烷三烯酸甲酯,all-cis-8,11,14-Eicosatrienoic acid,Ro 12-1989 |
Others | Others |
Ro 12-1989 can be converted into prostaglandin E1 (PGE1). Ro 12-1989 competes with arachidonic acid for COX and lipoxygenase, inhibiting the production of arachidonic acid's eicosanoids. |